Lux Capital Management related stories
All articles and analysis
peHUB Wire: Wednesday, February 10, 2010Random Ramblings
- Venture Capital: Who (Not What) Is Broken
Reports of venture capital’s demise are greatly exaggerated. Not a day goes by without a commentator reading the VC industry its last rites. And many of the gloomiest prognostications come from those inside the industry. A recent survey /60650/is-the-venture-capital-business-broken/ found that 53% of VC respondents felt the industry was broken. It’s too easy and lazy (and self-serving for some) to claim the VC model as broken. Nineties nostalgia recalls VC as an investment strategy played on Lake Wobegon, where the sun always shined, all portfolio companies were above average, prices always moved higher and everyone came away a winner.
- Ten VC Predictions for 2010: Outrunning The Bear
He who loses less, wins? Venture capital in the 2000s was much akin to the joke about the two campers who cross paths with a bear. As the angry bear begins charging out of the woods towards the campers, the first camper starts putting his sneakers on. The other camper screams, "It's no use, we'll never be able to outrun the bear!" And the first camper yells back, "I don't need to outrun the bear, I just need to outrun you!" Over the past decade, venture capitalists could claim top-quartile performance just by showing smaller losses than the rest of the pack. The start of 2010 provides a clean slate—that is, after we break out the scorecard and grade last year’s predictions.
- Week in deals, Nov. 9, 2009
Summary of North American tech companies and other startups that raised venture financing in the past week
- peHUB Wire: Wednesday, November 4, 2009
56,000 and Counting…
- peHUB Wire: Wednesday, November 4, 2009
56,000 and Counting…
- Cambrios Raises $14.5 Million
Cambrios Technologies Corp., a Mountain View, Calif.-based provider of bio-directed materials for the electronics industry, has held a $9 million first close on a guaranteed $14.5 million in a first close on its Series D round. Sumitomo Corp.,Chisso Corp. and Nissha Printing Co. were joined by return backers included ARCH Venture Partners, Alloy Ventures, Oxford Bioscience Partners, Harris & Harris Group, Altitude Life Science Ventures, Presidio Ventures, Mitsubishi UFJ Capital, In-Q-Tel, Avalon Ventures, Lux Capital, Kidron LLC, Headland Ventures and Alexandria Real Estate Equities.
- Week in deals, August 3, 2009
Summary of North American tech companies and other businesses that raised venture-related financing in the past week
- Cerulean Pharma Raises $10 Million
Cerulean Pharma Inc. , a Cambridge, Mass.-based developer of nanoparticle-based drugs, has raised $10 million in Series B-1 funding. Return backers include Polaris Venture Partners, Venrock, Lux Capital and Bessemer Venture Partners. The company had previously raised around $20 million, and last month signed a worldwide licensing agreement for a drug delivery technology and clinical-stage oncology product candidate developed by Calando Pharmaceuticals Inc., a majority-owned subsidiary of Arrowhead Research Corp. (Nasdaq: ARWR).
- peHUB Wire: Tuesday, July 28, 2009
Random Ramblings